In short
Non-alcoholic fatty liver disease (NAFLD) is the accumulation of excess fat in liver cells, driven by insulin resistance, excess fructose and refined carbohydrate intake, gut dysfunction, and systemic metabolic imbalance. At CLCC, care for fatty liver follows a five-step structured assessment: Assess, Identify, Reduce, Restore, Continue, addressing the systemic contributors alongside standard medical treatment, rather than symptom management alone.
About This Condition
Fatty liver is the liver's expression of metabolic dysfunction, not a standalone liver condition.
Non-alcoholic fatty liver disease (NAFLD) is the accumulation of excess fat in liver cells, driven by insulin resistance, excess fructose and refined carbohydrate intake, gut dysfunction, and systemic metabolic imbalance. It is now the most common liver condition globally, and is almost universally underdiagnosed because it is clinically silent until liver enzymes are elevated on a routine blood test.
Standard management advice for fatty liver is 'lose weight and eat less sugar.' This is correct but structurally inadequate. The liver fat is the downstream consequence of insulin resistance, gut dysbiosis, and dietary patterns, all of which must be specifically and simultaneously addressed. Liver-specific supplementation that supports hepatic fat metabolism and reduces oxidative stress in liver tissue provides targeted support that dietary correction alone cannot achieve. CLCC addresses all three dimensions simultaneously.
Symptoms
Common symptoms and presentations.
Elevated SGPT (ALT) or SGOT (AST) on routine blood testing
Fatty liver finding on abdominal ultrasound
Fatigue and right upper abdominal discomfort in some patients
Often completely asymptomatic, discovered incidentally
Associated elevated triglycerides and blood sugar
Associated central weight gain and insulin resistance markers
Persistent enzyme elevation despite previous dietary attempts
Progression to NASH (inflammatory fatty liver) in untreated cases
Contributing Factors
What drives and sustains this condition.
Insulin resistance and hyperinsulinaemia
Elevated insulin drives hepatic lipogenesis, converting excess glucose into fat stored in liver tissue. Correcting insulin resistance is the primary clinical goal in fatty liver management.
Excess fructose and refined carbohydrate intake
Fructose is metabolised almost exclusively in the liver and is the most direct dietary driver of hepatic fat accumulation. Structured dietary correction eliminating excess fructose is essential.
Gut microbiome dysfunction
Dysbiotic gut bacteria produce bacterial metabolites, including lipopolysaccharides, that directly promote hepatic inflammation and fat accumulation through the gut-liver axis.
Oxidative stress
Liver cells under metabolic load produce excess reactive oxygen species that damage hepatocytes and promote inflammatory progression from simple fatty liver to NASH.
The CLCC Method: All Five Steps
Assessment first. Then all five steps, applied specifically.
Full hepatic and metabolic assessment
Liver enzymes, fasting insulin, HbA1c, lipid profile, abdominal ultrasound findings, and gut health indicators assessed together. Dietary patterns reviewed in detail for fructose load and glycaemic impact.
Map the specific hepatic contributors
Insulin resistance vs excess fructose vs gut dysbiosis vs oxidative stress, the dominant contributors determine which components of the care plan are prioritised and at what intensity.
Structured anti-fructose dietary protocol with liver-specific supplementation
Dietary elimination of excess fructose and refined carbohydrates. Liver-supportive supplementation. Gut microbiome restoration. Metabolic correction through insulin sensitivity improvement. All implemented simultaneously.
Track liver enzymes and metabolic markers at intervals
SGPT/SGOT, HbA1c, fasting insulin, and triglycerides reviewed at structured intervals. Liver enzyme normalisation is a measurable marker of hepatic fat reduction.
Sustain hepatic health, fatty liver recurs with dietary and metabolic relapse
Dietary patterns and metabolic correction must be sustained. Fatty liver is a metabolically reversible condition, but it recurs when the metabolic environment that produced it is restored.
FAQs
Common questions about care.
Can fatty liver be reversed?+
Yes. Non-alcoholic fatty liver is reversible with appropriate metabolic and dietary correction. Liver enzyme normalisation typically occurs within 3–6 months of structured intervention. Complete hepatic fat clearance may take 6–12 months depending on severity. Early-stage NAFLD is more rapidly reversible than advanced fibrosis.
Do I need a liver specialist for fatty liver?+
For simple NAFLD without fibrosis, the most common presentation, structured metabolic and dietary care is the primary management approach. A hepatology assessment is appropriate for elevated enzymes that do not respond to dietary correction, suspected fibrosis, or signs of progressive liver disease.